Open Access
Open access
JIMD Reports, volume 63, issue 4, pages 341-350

Method development and validation for analysis of phenylalanine, 4‐hydroxyphenyllactic acid and 4‐hydroxyphenylpyruvic acid in serum and urine

Publication typeJournal Article
Publication date2022-04-03
Journal: JIMD Reports
Quartile SCImago
Q3
Quartile WOS
Impact factor
ISSN21928304, 21928312, 21928312
Endocrinology, Diabetes and Metabolism
Internal Medicine
Biochemistry, Genetics and Molecular Biology (miscellaneous)
Abstract
Alkaptonuria (AKU) is a rare debilitating autosomal recessive disorder of tyrosine (TYR) metabolism which results in a deficiency of the enzyme homogentisate 1,2-dioxygenase activity. Several studies have reported the metabolic changes in homogentisic acid (HGA) concentrations and subsequent deposition of an ochronotic pigment in connective tissues, especially cartilage. Treatment with nitisinone (NTBC) reduces urinary and circulating HGA, but its mode of action results in hypertyrosinaemia. The effect of NTBC on other metabolites in the TYR pathway has not been reported. Modification of the current reverse phase liquid chromatography tandem mass spectrometry methods for serum and urine to include phenylalanine (PHE), hydroxyphenyllactate (HPLA) and hydroxyphenylpyruvate (HPPA) has been validated. HPPA and HPLA (negative ionisation) eluted at 2.8 and 2.9 min respectively on an Atlantis C18 column with PHE (positive ionisation) eluting earlier at 2.4 min. Intra- and inter-assay accuracy was between 96.3% and 100.3% for PHE; 96.6% and 110.5% for HPLA and 95.0% and 107.8% for HPPA in both urine and serum. Precision, both inter- and intra-assay, was <10% for all analytes in both serum and urine. No significant issues with carry-over, stability or matrix interferences were seen in either the urine or serum assays. Measurement of serum and urine from AKU patients has demonstrated a robust, fully validated assay, appropriate for monitoring of patients with AKU and for demonstrating metabolite changes, following NTBC therapy.

Top-30

Citations by journals

1
2
3
Metabolites
3 publications, 42.86%
Biomolecules
1 publication, 14.29%
Journal of Inherited Metabolic Disease
1 publication, 14.29%
Russian Chemical Reviews
1 publication, 14.29%
1
2
3

Citations by publishers

1
2
3
4
Multidisciplinary Digital Publishing Institute (MDPI)
4 publications, 57.14%
Wiley
1 publication, 14.29%
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
1 publication, 14.29%
1
2
3
4
  • We do not take into account publications without a DOI.
  • Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
Share
Cite this
GOST |
Cite this
GOST Copy
Hughes A. T. et al. Method development and validation for analysis of phenylalanine, 4‐hydroxyphenyllactic acid and 4‐hydroxyphenylpyruvic acid in serum and urine // JIMD Reports. 2022. Vol. 63. No. 4. pp. 341-350.
GOST all authors (up to 50) Copy
Hughes A. T., Milan A. M., Shweihdi E., Gallagher J., RANGANATH L. Method development and validation for analysis of phenylalanine, 4‐hydroxyphenyllactic acid and 4‐hydroxyphenylpyruvic acid in serum and urine // JIMD Reports. 2022. Vol. 63. No. 4. pp. 341-350.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1002/jmd2.12287
UR - https://doi.org/10.1002/jmd2.12287
TI - Method development and validation for analysis of phenylalanine, 4‐hydroxyphenyllactic acid and 4‐hydroxyphenylpyruvic acid in serum and urine
T2 - JIMD Reports
AU - Hughes, Andrew T
AU - Shweihdi, Ella
AU - Gallagher, James
AU - Milan, Anna M.
AU - RANGANATH, L.
PY - 2022
DA - 2022/04/03 00:00:00
PB - Springer Nature
SP - 341-350
IS - 4
VL - 63
SN - 2192-8304
SN - 2192-8312
SN - 2192-8312
ER -
BibTex |
Cite this
BibTex Copy
@article{2022_Hughes,
author = {Andrew T Hughes and Ella Shweihdi and James Gallagher and Anna M. Milan and L. RANGANATH},
title = {Method development and validation for analysis of phenylalanine, 4‐hydroxyphenyllactic acid and 4‐hydroxyphenylpyruvic acid in serum and urine},
journal = {JIMD Reports},
year = {2022},
volume = {63},
publisher = {Springer Nature},
month = {apr},
url = {https://doi.org/10.1002/jmd2.12287},
number = {4},
pages = {341--350},
doi = {10.1002/jmd2.12287}
}
MLA
Cite this
MLA Copy
Hughes, Andrew T., et al. “Method development and validation for analysis of phenylalanine, 4‐hydroxyphenyllactic acid and 4‐hydroxyphenylpyruvic acid in serum and urine.” JIMD Reports, vol. 63, no. 4, Apr. 2022, pp. 341-350. https://doi.org/10.1002/jmd2.12287.
Found error?